Community-Acquired Methicillin-Resistant Staphylococcus aureus Infections in Children

Seminars in Pediatric Infectious Diseases

Volumn 17, Issue 3, 2006, Pages 113-119

  Kaplan, Sheldon L ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; AUREXIS; BETA LACTAM ANTIBIOTIC; CEFALEXIN; CEFAZOLIN; CLINDAMYCIN; COTRIMOXAZOLE; DAPTOMYCIN; DICLOXACILLIN; DOXYCYCLINE; GENTAMICIN; IMMUNOGLOBULIN G ANTIBODY; LINEZOLID; MINOCYCLINE; NAFCILLIN; OXACILLIN; PSEUDOMONIC ACID; PYRIDOXINE; RIFAMPICIN; TIGECYCLINE; VANCOMYCIN;

ABSCESS; ABSCESS DRAINAGE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL ENDOCARDITIS; BACTERIAL TRANSMISSION; BACTERIAL VIRULENCE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BONE MARROW SUPPRESSION; CELLULITIS; CHILDHOOD DISEASE; CLINICAL FEATURE; COMMUNITY ACQUIRED PNEUMONIA; DIARRHEA; DRUG EFFICACY; DRUG HYPERSENSITIVITY; EMPYEMA; EXTERNAL OTITIS; FOLLICULITIS; FULMINATING PURPURA; HUMAN; INFECTION SENSITIVITY; LABORATORY; LACTIC ACIDOSIS; LOOSE FECES; LYMPHADENITIS; MASTOIDITIS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MYOSITIS; NECROTIZING FASCIITIS; OPTIC NEURITIS; OSTEOMYELITIS; OTITIS MEDIA; PERIPHERAL NEUROPATHY; PNEUMONIA; POLYMYOSITIS; RASH; SKIN INFECTION; SOFT TISSUE INFECTION; STAPHYLOCOCCUS INFECTION; THROMBOCYTOPENIA;

ADOLESCENT; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; COMMUNITY-ACQUIRED INFECTIONS; HUMANS; METHICILLIN RESISTANCE; MICROBIAL SENSITIVITY TESTS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; UNITED STATES;

EID: 33747778054     PISSN: 10451870     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.spid.2006.06.004     Document Type: Article

References (65)

1. Herold B.C., Immergluck L.C., Maranan M.C., et al. Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. JAMA 279 (1998) 593-598
2. Purcell K., and Fergie J.E. Exponential increase in community-acquired methicillin-resistant Staphylococcus aureus infections in South Texas children. Pediatr Infect Dis J 21 (2002) 988-989
3. Fridkin S.K., Hageman J.C., Morrison M., et al. Methicillin-resistant Staphylococcus aureus disease in three communities. N Engl J Med 352 (2005) 1436-1444
4. Kaplan S.L., Hulten K.G., Gonzalez B.E., et al. Three-year surveillance of community-acquired Staphylococcus aureus infections in Children. Clin Infect Dis 40 (2005) 1785-1791
5. O'Brien F.G., Lim T.T., Chong F.N., et al. Diversity among community isolates of methicillin-resistant Staphylococcus aureus in Australia. J Clin Microbiol 42 (2004) 3185-3190
6. Chen C.-J., and Huang Y.-C. Community-acquired methicillin-resistant Staphylococcus aureus in Taiwan. J Microbiol Immunol Infect 38 (2005) 376-382
7. Ma X.X., Galiana A., Pedreira W., et al. Community-acquired methicillin-resistant Staphylococcus aureus, Uruguay. Emerg Infect Dis 11 (2005) 973-976
8. McDougal L.K., Steward C.D., Killgore G.E., et al. Pulsed-field gel electrophoresis typing of oxacillin-resistant Staphylococcus aureus isolates from the United States. establishing a national database. J Clin Microbiol 41 (2003) 5113-5120
9. Centers for Disease Control. Methicillin-resistant Staphylococcus aureus infections among competitive sports participants-Colorado, Indiana, Pennsylvania, and Los Angeles County, 2000-2003. MMWR Morb Mortal Wkly Rep 22 52 (2000) 793-795
10. Adcock P.M., Pastor P., Medley F., Patterson J.E., and Murphy T.V. Methicillin-resistance Staphylococcus aureus in two child care centers. J Infect Dis 178 (1998) 577-580
11. Ma X.X., Ito T., Tiensasitorn C., et al. A novel type of staphylococcal cassette chromosome mec (SCCmec) identified in community-acquired methicillin- resistant Staphylococcus aureus strains. Antimicrob Agents Chemother 46 (2002) 1147-1152
12. Healy C.M., Hulten K.G., Palazzi D.L., et al. Emergence of new strains of methicillin-resistant Staphylococcus aureus in a neonatal intensive care unit. Clin Infect Dis 39 (2004) 1460-1466
13. Klevens R.M., Edwards J.R., Tenover F.C., et al. Changes in the epidemiology of methicillin-resistant Staphylococcus aureus in intensive care units in US hospitals. Clin Infect Dis 42 (2006) 389-391
14. Bratu S., Eramo A., Kopec R., et al. Community-associated methicillin-resistant Staphylococcus aureus in hospital nursery and maternity units. Emerg Infect Dis 11 (2005) 808-813
15. Hulten K.G., Kaplan S.L., Gonzalez B.E., et al. Three-year surveillance of community onset healthcare-associated Staphylococcus aureus infections in children. Pediatr Infect Dis J 25 (2006) 349-353
16. Crawford S.E., and Daum R.S. Epidemic community-associated methicillin-resistant Staphylococcus aureus. Modern times for an ancient pathogen. Pediatr Infect Dis J 24 (2005) 459-460
17. Tenover F.C., McDougal L.K., Goering R.V., et al. Characterization of a strain of community-acquired methicillin-resistant Staphylococcus aureus widely disseminated in the United States. J Clin Microbiol 44 (2006) 108-118
18. Mishaan A.M.A., Mason Jr. E.O., Martinez-Aguilar G., et al. Emergence of a predominant clone of community-acquired Staphylococcus aureus among children in Houston, TX. Pediatr Infect Dis J 24 (2005) 201-206
19. Centers for Disease Control and Prevention. Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus-Minnesota and North Dakota, 1997-1999. MMWR Morb Mortal Wkly Rep 48 (1999) 707-710
20. Baba T., Takeuchi F., Kuroda M., et al. Genome and virulence determinants of high virulence community-acquired MRSA. Lancet 359 (2002) 1819-1827
21. Diep B.A., Gill S.R., Chang R.F., et al. Complete genome sequence of USA300, an epidemic clone of community-acquired meticillin-resistant Staphylococcus aureus. Lancet 367 (2006) 731-739
22. Elasri M.O., Thomas J.R., Skinner R.A., et al. Staphylococcus aureus collagen adhesin contributes to the pathogenesis of osteomyelitis. Bone 30 (2002) 275-280
23. Vandenesch F., Naimi T., Enright M.C., et al. Community-acquired methicillin- resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes. worldwide emergence. Emerg Infect Dis 9 (2003) 978-984
24. Gillet Y., Issartel B., Vanhems P., et al. Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotizing pneumonia in young immunocompetent patients. Lancet 359 (2002) 753-759
25. Martinez-Aguilar G., Avalos-Mishaan A., Hulten K., et al. Community-acquired, methicillin-resistant and methicillin-susceptible Staphylococcus aureus musculoskeletal infections in children. Pediatr Infect Dis J 23 (2004) 701-706
26. Bocchini C.E., Hulten K.G., Mason Jr. E.O., et al. Panton-Valentine Leukocidin genes are associated with enhanced inflammatory response and local disease in acute hematogenous Staphylococcus aureus osteomyelitis in children. Pediatrics 117 (2006) 433-440
27. Gonzalez B.E., Hulten K.G., Dishop M.K., et al. Pulmonary manifestations in children with invasive community-acquired Staphylococcus aureus infections. Clin Infect Dis 41 (2005) 583-590
28. Santos F.A.B., Mankarious L.A., and Eavey R.D. Methicillin-resistant Staphylococcus aureus. pediatric otitis. Arch Otolaryngol Head Neck Surg 126 (2000) 1383-1385
29. Gonzalez B.E., Teruya J., Mahoney Jr. D.H., et al. Venous thrombosis associated with staphylococcal osteomyelitis. Pediatrics 117 (2006) 1673-1679
30. Pannaraj P.S., Hulten K.G., Gonzalez B.E., et al. Myositis and pyomyositis in the Era of methicillin-resistant Staphylococcus aureus. Program & Abstracts. 42nd Annual Meeting of the IDSA. October 7 (2005) Boston, MA (abstr 556)
31. Trusen A., Beissert M., Schultz G., et al. Ultrasound and MRI features of pyomyositis in children. Eur Radiol 13 (2003) 1050-1055
32. Miller L.G., Perdreau-Remington F., Rieg G., et al. Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles. N Engl J Med 352 (2005) 1445-1453
33. Schultz K.D., Fan L.F., Pinsky J., et al. The changing face of pleural empyemas in children. epidemiology and management. Pediatrics 113 (2004) 1735-1740
34. Hageman J.C., Uyeki T.M., Francis J.S., et al. Severe community-acquired pneumonia due to Staphylococcus aureus, 2003-04 influenza season. Emerg Infect Dis 12 (2006) 894-899
35. Mongkolrattanothai K., Boyle S., Kahana M.D., et al. Severe Staphylococcus aureus infections caused by clonally related community-acquired methicillin- susceptible and methicillin-resistant isolates. Clin Infect Dis 37 (2003) 1050-1058
36. Gonzalez B.E., Martinez-Aguilar G., Hulten K.G., et al. Severe Staphylococcal sepsis in adolescents in the era of community-acquired methicillin-resistant Staphylococcus aureus. Pediatrics 115 (2004) 642-648
37. Valente A.M., Jain R., Scheurer M., et al. Frequency of infective endocarditis among infants and children with Staphylococcus aureus bacteremia. Pediatrics 115 (2005) e15-e19
38. Kravitz G.R., Dries D.J., Peterson M.L., et al. Purpura fulminans due to Staphylococcus aureus. Clin Infect Dis 40 (2005) 941-947
39. Adem P.V., Montgomery C.P., Husain A.N., et al. Staphylococcus aureus sepsis and the Waterhouse-Friderichsen syndrome in children. N Engl J Med 353 (2005) 1245-1251
40. Fortunov, RM, Hulten, KG, Hammerman, WA, et al: Community-acquired Staphylococcus aureus infections in term and near-term previously healthy neonates. Presented at the Annual Meeting of the Pediatric Academic Societies. San Francisco, CA. April 29, 2006 (abstr 2753.6)
41. Warren D.K., Liao R.S., Merz L.R., et al. Detection of methicillin-resistant Staphylococcus aureus directly from nasal swab specimens by a real-time PCR assay. J Clin Microbiol 42 (2004) 5578-5581
42. Lewis II J.S., and Jorgensen J.H. Inducible clindamycin resistance in staphylococci. should clinicians and microbiologists be concerned?. Clin Infect Dis 40 (2005) 280-285
43. Lee M.C., Riso A.M., Aten M.F., et al. Management and outcome of children with skin and soft tissue abscesses caused by community-acquired methicillin-resistant Staphylococcus aureus. Pediatr Infect Dis J 23 (2004) 123-127
44. Marcinak J.F., and Frank A.L. Treatment of community-acquired methicillin-resistant Staphylococcus aureus in children. Curr Opin Infect Dis 16 (2003) 265-269
45. Adra M., and Lawrence K.R. Trimethoprim/sulfamethoxazole for treatment of severe Staphylococcus aureus infections. Ann Pharmacother 38 (2004) 338-341
46. Iyer S., and Jones D.H. Community-acquired methicillin-resistant Staphylococcus aureus skin infections. a retrospective analysis of clinical presentation and treatment of a local outbreak. J Am Acad Dermatol 50 (2004) 854-858
47. Ardati K.O., Thirumoorthi M.C., and Dajani A.S. Intravenous trimethoprim-sulfamethoxazole in the treatment of serious infections in children. J Pediatr 95 (1979) 801-806
48. Hyun, DY, Mason, EO Jr, Hammerman, WA, et al: Trimethoprim-sulfamethoxazole in the management of community-acquired methicillin-resistant Staphylococcus aureus skin and soft tissue infections. Presented at the Annual Meeting of the Pediatric Academic Societies. San Francisco, CA. April 30, 2006 (abstr 3526.167)
49. Ruhe J.J., Monson T., Bradsher R.W., et al. Use of long-acting tetracyclines for methicillin-resistant Staphylococcus aureus infections. case series and review of the literature. Clin Infect Dis 40 (2005) 1029-1034
50. Shelburne S.A., Musher D.M., Hulten K., et al. In vitro killing of community-associated methicillin-resistant Staphylococcus aureus with drug combinations. Antimicrob Agents Chemother 48 (2004) 4016-4019
51. Gonzalez C., Rubio M., Romero-Vivas J., et al. Bacteremic pneumonia due to Staphylococcus aureus. a comparison of disease caused by methicillin-resistant and methicillin-susceptible organisms. Clin Infect Dis 29 (1999) 1171-1177
52. Frank A.L., Marcinak J.F., Mangat P.D., et al. Clindamycin treatment of methicillin-resistant Staphylococcus aureus infections in children. Pediatr Infect Dis J 21 (2002) 530-534
53. Martinez-Aguilar G., Hammerman W.A., Mason Jr. E.O., et al. Clindamycin treatment of invasive infections caused by community-acquired, methicillin- resistant and methicillin-susceptible Staphylococcus aureus in children. Pediatr Infect Dis J 22 (2003) 593-598
54. Kaplan S.L., Deville J.G., Yogev R., et al. Linezolid versus vancomycin for treatment of resistant Gram-positive infections in children. Pediatr Infect Dis J 22 (2003) 677-686
55. Wunderink R.G., Rello J., Cammarata S.K., et al. Linezolid vs vancomycin. analysis of two double-blind studies of patients with methicillin- resistant Staphylococcus aureus nosocomial pneumonia. Chest 124 (2003) 1789-1797
56. Rayner C.R., Baddour L.M., Birmingham M.C., et al. Linezolid in the treatment of osteomyelitis. results of compassionate use experience. Infection 32 (2004) 8-14
57. Rao N., Ziran B.H., Hall R.A., et al. Successful treatment of chronic bone and joint infections with oral linezolid. Clin Orthop Relat Res 427 (2004) 67-71
58. Spellberg B., Yoo T., and Bayer A.S. Reversal of linezolid-associated cytopenias, but not peripheral neuropathy, by administration of vitamin B6. J Antimicrob Chemother 54 (2004) 832-835
59. Arbeit R.D., Maki D., Tally F.P., et al. The safety and efficacy of daptomycin for the treatment of complicated skin and skin-structure infections. Clin Infect Dis 38 (2004) 1673-1681
60. Ellis-Grosse E.J., Babinchak T., Dartois N., et al. The efficacy and safety of tigecycline in the treatment of skin and skin-structure infections. results of 2 double- blind phase 3 comparison studies with vancomycin-aztreonam. Clin Infect Dis 41 suppl (2005) S341-S353
61. Baker C.J., and Frenck Jr. R.W. Change in management of skin/soft tissue infections needed. AAP News 25 (2004) 105
62. Gauduchon V., Cozon G., Vandenesch F., et al. Neutralization of Staphylococcus aureus Panton Valentine leukocidin by intravenous immunoglobulin in vitro. J Infect Dis 189 (2004) 346-353
63. http://www.inhibitex.com/publications/AUR002 ICAAC Slides - Aurexis Phase II Presentation ICAAC Dec 2005.pdf. Accessed June 29, 2006
64. Chen S.F. Staphylococcus aureus decolonization. Pediatr Infect Dis J 24 (2005) 70-80
65. Deshpande L.M., Fix A.M., Pfaller M.A., et al. Emerging elevated mupirocin resistance rates among staphylococcal isolates in the SENTRY antimicrobial surveillance program (2000). correlations of results from disk diffusion, Etest and reference dilution methods. Diagn Microbiol Infect Dis 42 (2002) 283-290